Decheng Capital

Decheng Capital

Decheng Capital

Follow us
Alexa global traffic share
Latest investments Show all
$91,000,000
Post-IPO equity
Alpine Immune Sciences
$150,000,000
Venture capital (Series D)
Mammoth Biosciences
Team Size
1–10
Employees
Location
Headquarters
Past year's investments
  • 3 rounds in the past year
  • $353M deployed in total
  • $117.7M avg per round
Latest rounds
  • Alpine Immune Sciences: Post-IPO equity ($91M)
  • Mammoth Biosciences: Venture capital (Series D) ($150M)
  • ShapeTX: Venture capital (Series B) ($112M)